Fibronostics is a healthcare technology company providing algorithm-based solutions in a variety of diagnostic testing areas, focusing on assessing liver disease existence/progression, but also other chronic areas such as coronary heart disease, stroke, diabetes, and obstructive sleep apnea. Fibro...See more
Headquarters:
United States of America
Company Type:
SME
Company size:
11-50 Employees
Year Founded:
2015 (11 years)
Address:
615 BARONNE ST; SUITE 100; NEW ORLEANS, LOUISIANA 70113, US
The company has corporate shareholder(s) or more than 20 individual shareholders
The company has a sophisticated ownership structure and may be part of a large corporate group
HIGH
spending power